Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

NERRE THERAPEUTICS LTD

Company number 07916206

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
11 Apr 2024 CH01 Director's details changed for Mr Andrew Kay on 9 April 2024
16 Mar 2024 AA Full accounts made up to 30 June 2023
19 Feb 2024 CS01 Confirmation statement made on 15 February 2024 with no updates
24 May 2023 CH01 Director's details changed for Mr Javier García Cogorro on 25 June 2021
19 May 2023 CH01 Director's details changed for Mr Andrew Kay on 1 March 2023
18 May 2023 CH01 Director's details changed for Dr Ena Prosser on 15 April 2019
21 Mar 2023 AA Full accounts made up to 30 June 2022
15 Feb 2023 CS01 Confirmation statement made on 15 February 2023 with no updates
25 Mar 2022 AA Full accounts made up to 30 June 2021
15 Feb 2022 CS01 Confirmation statement made on 15 February 2022 with no updates
26 Jul 2021 PSC08 Notification of a person with significant control statement
07 Jul 2021 AA Full accounts made up to 30 June 2020
30 Jun 2021 AP01 Appointment of Mr Javier García Cogorro as a director on 25 June 2021
30 Jun 2021 PSC07 Cessation of Advent Life Sciences Llp as a person with significant control on 25 June 2021
17 Feb 2021 CS01 Confirmation statement made on 15 February 2021 with no updates
18 Mar 2020 AA Full accounts made up to 30 June 2019
20 Feb 2020 CS01 Confirmation statement made on 15 February 2020 with no updates
01 Mar 2019 AA Full accounts made up to 30 June 2018
26 Feb 2019 CS01 Confirmation statement made on 15 February 2019 with no updates
27 Feb 2018 CS01 Confirmation statement made on 15 February 2018 with updates
28 Nov 2017 AA Full accounts made up to 30 June 2017
16 Nov 2017 AP01 Appointment of Mr Andrew Kay as a director on 15 September 2017
09 Oct 2017 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
08 Sep 2017 SH19 Statement of capital on 8 September 2017
  • GBP 2,728.8121
08 Sep 2017 SH20 Statement by Directors